China Resources Pharmaceutical Group Breaks Ground on HDR-designed Beijing Campus
(October 25, 2013) - China Resources Pharmaceutical Group, the second-largest pharmaceutical company in China, recently broke ground on its new campus in the Daxing District of Beijing. The approximately US $2 billion campus project, designed by HDR, will consolidate all company functions into an approximately 8-million-square-feet (700,000-m²) series of buildings to be built at one time.
"This is an opportunity for China Resources to unify all of its disparate parts and rebrand itself as one of the leading pharmaceutical companies in the world," said Brian Kowalchuk, HDR's global director of design. "The design of the campus will integrate local Chinese ideals and culture with Western design standards, blending the best of both and resulting in a world-class campus in the truest sense. Most importantly, though, it will facilitate new collaborations among research groups and shorten the time frame between research, production, and distribution of pharmaceuticals."
China Resources Pharmaceutical Group is one of the seven core entities of China Resources (Holding) Co., Ltd, which is ranked 187 in the Fortune Global 500. The Pharmaceutical Group recently acquired a number of smaller research and pharmaceutical companies, and the new campus consolidates all functions onto one site.
"The expansion of China Resources Pharmaceutical Group and the creation of its new, world-class campus is a key component in China's current five-year plan," said Yong Sun, HDR's director of operations for china. "The plan focuses on improving the health and wellness of Chinese citizens, and this new campus provides the spaces and tools necessary to bring the plan to life."
Both Kowalchuk and Sun, along with HDR's Beijing staff, attended the groundbreaking for the new campus. Key government officials also attended, including the Vice Chairman of the Standing Committee of the National People's Congress, Sang Guowei, as well as the Vice Mayor of Beijing and leaders from the Ministry of Health, Department of S&T, National Development and Reform Commission, and the China Food and Drug Administration. Representatives from the world's top 10 pharmaceutical companies were also in attendance signing contracts to collaborate with China Resources once its new campus opens in 2015.